| Document |
Document Title |
|
WO/2023/227757A1 |
The invention provides protected ortho-quinone compounds comprising a group represented by: Formula (I) where -Ar- is optionally substituted phenylene, -X is selected from -NH2, -OH and -SH, and the protected forms of each, -W- is option...
|
|
WO/2023/224020A1 |
Provided is a compound represented by formula (1). (The symbols in formula (1) are as defined in the specification.) Also provided are an organic electroluminescent element that contains the compound and an electronic device that include...
|
|
WO/2023/225645A1 |
The present disclosure pertains to a new synthetic method for the preparation of lactones, an important class of organoleptic compounds which find use in the flavor and fragrance industries.
|
|
WO/2023/223925A1 |
The present invention provides: a compound that, while being a curable resin, can easily achieve, when being formed into a cured product, the abilities to be repaired, to be easily disassembled, and to be remolded; and a curable resin co...
|
|
WO/2023/222559A1 |
The present invention relates to a process for preparing a deuterated organic compound, comprising the following steps: preparing a liquid composition comprising the organic compound, at least one heterogeneous metal catalyst, at least o...
|
|
WO/2023/221825A1 |
Provided in the present invention are a sesquiterpene derivative, a pharmaceutical composition thereof, and a preparation method therefor and the use thereof. The present invention relates to a sesquiterpene derivative as represented by ...
|
|
WO/2023/220461A1 |
Photo switchable photoinitiators comprising a photochromic molecule including one or more substituents and including a polycyclic group attached to the photochromic molecule as a substituent or to a substituent on the photochromic molecu...
|
|
WO/2023/220559A2 |
Disclosed herein is the catalyst-controlled site-selective activation of β- and γ-methylene C-H bonds of free carboxylic acids which heretofore was unknown and has remained a tremendous challenge. Described herein in the enablement of ...
|
|
WO/2023/219399A1 |
The present specification relates to a compound represented by Chemical Formula 1, a coating composition comprising the compound represented by Chemical Formula 1, an organic light-emitting device using same, and a manufacturing method t...
|
|
WO/2023/213922A1 |
The present invention primarily relates to compounds of formula (I) as defined herein. It also relates to fragrance substance mixtures as defined herein and methods for producing the same and to perfumed products as defined herein and me...
|
|
WO/2023/212999A1 |
The present application discloses a composite catalyst and a synthesis method for bio-based furan chemicals. The composite catalyst comprises tetravalent metal salt and acid metal salt. The synthesis method for bio-based furan chemicals ...
|
|
WO/2023/210363A1 |
Provided are a water-soluble fluorescent compound having a novel structure, and a method for producing the fluorescent compound. The fluorescent compound is represented by formula (1).
|
|
WO/2023/208133A1 |
The present invention relates to a novel crystal form of blarcamesine (hereinafter referred to as "compound I") hydrochloride, a method for preparing same, a pharmaceutical composition comprising the crystal form, and use of the crystal ...
|
|
WO/2023/211205A1 |
The present invention relates to a novel 5-PF-amino acid derivative (5-PF-AA); a method for preparing a 5-PF structured compound or a 5-PF-amino acid derivative; and a pharmaceutical composition containing 5-PF structured compound or a 5...
|
|
WO/2023/210608A1 |
The purpose of the present invention is to provide: a method for determining the presence or absence of an impurity in a mercapto heterocyclic compound using a simple process, and producing a refined (high purity) mercapto heterocyclic c...
|
|
WO/2023/205241A1 |
Disclosed are one or more compounds III comprising chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxytetrahydrofuran, and/or 1,4-butanediol, and salts of such compounds (GHB delivering compounds and salts thereof). Also disclosed...
|
|
WO/2023/205378A1 |
The natural product neurolenin D is isolated from Neurolaena lobata using continuous extraction, stirring over charcoal, flash column chromatography, and recrystallization. The secondary alcohol in this molecule is converted into a metha...
|
|
WO/2023/202377A1 |
The present application provides a deuterated composition, an organic electroluminescent device, and a display apparatus. The deuterated composition comprises a deuterated mixture prepared from compound A by means of a deuteration reacti...
|
|
WO/2023/202582A1 |
A compound of a GPR132 regulator, a pharmaceutically acceptable salt or ester, a prodrug, a stereoisomer, a hydrate, a solvate, a crystal form, or a metabolite form thereof, as well as a preparation method therefor and medicinal use ther...
|
|
WO/2023/202583A1 |
Disclosed are an FXR regulator and use thereof, and specifically disclosed are a compound represented by formula I, or a stereoisomer, a prodrug, a crystal form, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, ...
|
|
WO/2023/203120A1 |
The present invention relates to the field of recovering by-products obtained during the production of black pellet-type fuel having a high calorific value, from lignocellulosic biomass. More precisely, the invention relates to a method ...
|
|
WO/2023/205233A1 |
Disclosed are compounds comprising chemically modified gamma-hydroxybutyrate (GHB) having the structure of Formula I, and salts of such compounds (GHB delivering compounds and salts thereof). Also disclosed are compositions comprising at...
|
|
WO/2023/202198A1 |
The present application relates to an organic material, an electronic element, and an electronic apparatus. The organic material provided by the present application has a structure as shown in formula 1. The organic material is applied t...
|
|
WO/2023/203438A1 |
Through the present invention, the driving voltage of a light-emitting device is reduced, and light emission efficiency is enhanced. Provided is a light-emitting device having a first electrode, a second electrode, a light-emitting layer...
|
|
WO/2023/202578A1 |
The present invention relates to a GPCR regulator and use thereof, and particularly provides a compound represented by formula (I), or a stereoisomer, a prodrug, a crystal form, a pharmaceutically acceptable salt, a pharmaceutically acce...
|
|
WO/2023/205245A1 |
Disclosed are one or more compounds of formula (V) comprising chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxy tetra hydrofuran, and/or 1,4-butanediol, and salts of such compounds (GHB delivering compounds and salts thereof). A...
|
|
WO/2023/199832A1 |
The present invention provides a compound which is represented by formula (1). (Each of the symbols in formula (1) is as defined in the description.) The present invention also provides an organic electroluminescent element that contains...
|
|
WO/2023/200196A1 |
The present invention relates to an organic compound employed in an organic layer in an organic light-emitting device, such as a hole transport layer and an electron blocking layer. The organic compound according to the present invention...
|
|
WO/2023/200195A1 |
The present invention relates to an organic compound, which is employed for an organic layer, such as a hole transport layer or an electron block layer, of an organic light emitting diode. The organic compound according to the present in...
|
|
WO/2023/200226A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light-emitting device including the compound.
|
|
WO/2023/200225A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light-emitting device comprising same.
|
|
WO/2023/201251A1 |
A dried, solid composition comprising a compound of the structural formula (I) is provided: wherein R2 is an alkyl group having 1 to 6 carbon atoms, and wherein the composition has a particle/crystal size distribution of 20 to 500 micron...
|
|
WO/2023/197247A1 |
Disclosed are a QF-1 compound and a preparation method therefor. The preparation method for the QF-1 compound comprises: fermenting Aspergillus terreus in a fungus culture medium, extracting an obtained Aspergillus terreus fermentation p...
|
|
WO/2023/196538A1 |
Substituted benzofuran, benzothiophene, and indole carboxamide compounds, conjugates, and pharmaceutical compositions for use as immunotherapeutics in the treatment of cancer, such as solid tumors, are disclosed herein. The disclosed com...
|
|
WO/2023/193425A1 |
The present invention provides a method for preparing 2-methyltetrahydrofuran by using waste biomass and belongs to the technical field of chemical production. In preparation of 2-methyltetrahydrofuran in the present invention, a catalys...
|
|
WO/2023/195482A1 |
The present invention provides a compound and a material for organic electroluminescent elements, each of which further improves the performance of an organic EL element, an organic electroluminescent element which has further improved e...
|
|
WO/2023/195787A1 |
An organic compound represented by chemical formula 1 of the present invention can implement excellent hole transfer characteristics. In addition, at least one of a hole transport layer and a hole transport aid layer of an organic light ...
|
|
WO/2023/195791A1 |
The present invention relates to a phenylpropenone backbone compound, which is a novel chromanone or a ring-opened form thereof, and a composition for preventing or treating multiple myeloma comprising same as an active ingredient. The c...
|
|
WO/2023/191353A1 |
The present specification relates to a heterocyclic compound of chemical formula 1, an organic light-emitting device comprising same, and a composition comprising same for forming an organic layer.
|
|
WO/2023/190597A1 |
The present invention provides an organic electroluminescent element (1) wherein: a light emission band (5) comprises a first light emitting layer (51) and a second light emitting layer (52); the triplet energy T1(H1) of a first host mat...
|
|
WO/2023/192921A2 |
In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein is versatile polyene cyclization strategy that exploits conjugated b-ionyl derivatives. Photomediated disruption of the extended p-syst...
|
|
WO/2023/191533A1 |
The present invention relates to a thiobenzimidazole derivative preparation method, a novel intermediate therefor, and the like. The present invention uses an intermediate containing O-ethyl carbonodithioate or an intermediate containing...
|
|
WO/2023/190878A1 |
Provided is a tetrahydronaphthalene derivative that can be used as an LAT1-selective inhibitor and an LAT1-selective substrate. The present invention relates to a compound represented by formula (I) or a pharmaceutically acceptable sal...
|
|
WO/2023/186692A1 |
The present invention relates to a novel method for preparing cis-4-aminotetrahydrofuran-2-carboxylic acid acids of the general formula (I) and salts thereof.
|
|
WO/2023/192424A1 |
The invention provides volatile HD AC inhibiting compounds for agricultural and medicinal applications.
|
|
WO/2023/189503A1 |
The present invention causes a radiation-sensitive composition to contain a polymer including acid-labile group and a compound (Q) given by formula (1). In formula (1), L1 represents an ester group, -CO-NR3-, a (thio) ether group, or a s...
|
|
WO/2023/192817A1 |
Provided herein are compounds of Formula (I). Methods for the preparation of the compounds of Formula (I) and intermediates useful in the preparation of the compounds of Formula (I) are described herein. The compounds of Formula (I) may ...
|
|
WO/2023/192356A1 |
The application relates to the novel intermediates (rc1) and (rc2) and to processes for their preparation. The intermediates are useful for preparing the LpxC hydroxamic acid inhibitor (R)-4-(4-(4-(2H-1,2,3-triazol-2-yl)phenyl)-2-oxopyri...
|
|
WO/2023/191088A1 |
The present invention provides a polysaccharide which has a degree of polymerisation of 16-40 and is composed only of galactose or composed only of galactose and 1-3 molecules of arabinose, the saccharide units of said polysaccharide bei...
|
|
WO/2023/182519A1 |
An ascorbic acid derivative or a salt thereof that contains a structure in which at least one of hydroxyl groups contained in ascorbic acid has been substituted with an ether bond attached to a carbon atom.
|
